These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An update on the management of Chagas cardiomyopathy. Rocha MO, Teixeira MM, Ribeiro AL. Expert Rev Anti Infect Ther; 2007 Aug; 5(4):727-43. PubMed ID: 17678433 [Abstract] [Full Text] [Related]
3. Chagas cardiomyopathy and heart failure: From epidemiology to treatment. Santos É, Menezes Falcão L. Rev Port Cardiol (Engl Ed); 2020 May; 39(5):279-289. PubMed ID: 32532535 [Abstract] [Full Text] [Related]
4. Medical treatment of cardiac arrhythmias in Chagas' heart disease. de Paola AA, Gondin AA, Hara V, Mendonça A. Sao Paulo Med J; 1995 May; 113(2):858-61. PubMed ID: 8650487 [Abstract] [Full Text] [Related]
5. Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment. Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. J Am Coll Cardiol; 2017 Sep 19; 70(12):1510-1524. PubMed ID: 28911515 [Abstract] [Full Text] [Related]
6. Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy. Malcolm EL, Saunders AB, Vitt JP, Boutet BG, Hamer SA. J Vet Intern Med; 2022 May 19; 36(3):1100-1105. PubMed ID: 35388923 [Abstract] [Full Text] [Related]
10. [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic]. Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, Lafuente CA, Luciardi HL, Moncayo A, Molina L, Muñoz J, Puente S, Sanz G, Treviño B, Sergio-Salles X. Rev Esp Cardiol; 2007 Mar 19; 60(3):285-93. PubMed ID: 17394874 [Abstract] [Full Text] [Related]
17. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Muratore CA, Batista Sa LA, Chiale PA, Eloy R, Tentori MC, Escudero J, Lima AM, Medina LE, Garillo R, Maloney J. Europace; 2009 Feb 19; 11(2):164-8. PubMed ID: 19056745 [Abstract] [Full Text] [Related]
18. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV, PARADIGM-HF and ATMOSPHERE Investigators and Committees. Circ Heart Fail; 2017 Nov 19; 10(11):. PubMed ID: 29141857 [Abstract] [Full Text] [Related]
19. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB. Antimicrob Agents Chemother; 2005 Apr 19; 49(4):1521-8. PubMed ID: 15793134 [Abstract] [Full Text] [Related]
20. [Surgical treatment of cardiac arrhythmia refractory to medication in a patient with chronic chagasic cardiopathy]. Blandón R, De León LE, González B. Rev Med Panama; 1986 Sep 19; 11(3):164-70. PubMed ID: 3809620 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]